METHODS OF USE OF ANTI-SORTILIN ANTIBODIES

The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof. La pré...

Full description

Saved in:
Bibliographic Details
Main Authors ROSENTHAL, Arnon, LIAO, Yijie, WARD, Michael F, PAUL, Robert, YEH, Felix Leejia, LONG, Hua
Format Patent
LanguageEnglish
French
Published 09.06.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof. La présente divulgation concerne de manière générale l'utilisation d'anticorps qui se lient spécifiquement à un ou à plusieurs épitopes dans une protéine sortiline, par exemple la sortiline humaine ou la sortiline de mammifère, afin de traiter et/ou de retarder la progression d'une maladie, d'un trouble ou d'une lésion chez un individu le nécessitant.
Bibliography:Application Number: WO2021US72682